Dow Jones U.S. Pharmaceuticals Index


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Heska (XS, US)  Pharmaceuticals
1. Heska (XS, US)   Pharmaceuticals 100 12 98 97
2. Pernix Therapeutics (XS, US)  Pharmaceuticals
2. Pernix Therapeutics (XS, US)   Pharmaceuticals 71 14 13 60
3. Impax Laboratories (S, US)  Pharmaceuticals
3. Impax Laboratories (S, US)   Pharmaceuticals 69 44 74 100
4. Pfizer (XL, US)  Pharmaceuticals
4. Pfizer (XL, US)   Pharmaceuticals 68 48 87 69
5. Eli Lilly (XL, US)  Pharmaceuticals
5. Eli Lilly (XL, US)   Pharmaceuticals 63 17 9 19
6. Sagent (XS, US)  Pharmaceuticals
6. Sagent (XS, US)   Pharmaceuticals 59 85 72 90

January 1, 2014. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Lannett (S, US)   Pharmaceuticals
1. Lannett (S, US)   Pharmaceuticals 41 96 75 50
2. Assertio Therapeutics (XS, US)   Pharmaceuticals
2. Assertio Therapeutics (XS, US)   Pharmaceuticals 48 92 79 92
3. Nektar (S, US)   Pharmaceuticals
3. Nektar (S, US)   Pharmaceuticals 18 92 100 90
4. Akorn (M, US)   Pharmaceuticals
4. Akorn (M, US)   Pharmaceuticals 3 89 86 50
5. Sagent (XS, US)   Pharmaceuticals
5. Sagent (XS, US)   Pharmaceuticals 59 85 72 90
6. Prestige (M, US)   Pharmaceuticals
6. Prestige (M, US)   Pharmaceuticals 41 75 8 11
7. Pacira Pharma (S, US)   Pharmaceuticals
7. Pacira Pharma (S, US)   Pharmaceuticals 5 72 1 3
8. Vivus (XS, US)   Pharmaceuticals
8. Vivus (XS, US)   Pharmaceuticals 2 67 78 67

January 1, 2014. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Nektar (S, US)   Pharmaceuticals
1. Nektar (S, US)   Pharmaceuticals 18 92 100 90
2. Heska (XS, US)   Pharmaceuticals
2. Heska (XS, US)   Pharmaceuticals 100 12 98 97
3. Merck & Co. (XL, US)   Pharmaceuticals
3. Merck & Co. (XL, US)   Pharmaceuticals 49 5 91 48
4. Pfizer (XL, US)   Pharmaceuticals
4. Pfizer (XL, US)   Pharmaceuticals 68 48 87 69
5. Akorn (M, US)   Pharmaceuticals
5. Akorn (M, US)   Pharmaceuticals 3 89 86 50
6. Assertio Therapeutics (XS, US)   Pharmaceuticals
6. Assertio Therapeutics (XS, US)   Pharmaceuticals 48 92 79 92
7. Vivus (XS, US)   Pharmaceuticals
7. Vivus (XS, US)   Pharmaceuticals 2 67 78 67
8. Endocyte (XS, US)   Pharmaceuticals
8. Endocyte (XS, US)   Pharmaceuticals 7 45 77 96
9. Lannett (S, US)   Pharmaceuticals
9. Lannett (S, US)   Pharmaceuticals 41 96 75 50
10. Impax Laboratories (S, US)   Pharmaceuticals
10. Impax Laboratories (S, US)   Pharmaceuticals 69 44 74 100

January 1, 2014. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Impax Laboratories (S, US)   Pharmaceuticals
1. Impax Laboratories (S, US)   Pharmaceuticals 69 44 74 100
2. Heska (XS, US)   Pharmaceuticals
2. Heska (XS, US)   Pharmaceuticals 100 12 98 97
3. Endocyte (XS, US)   Pharmaceuticals
3. Endocyte (XS, US)   Pharmaceuticals 7 45 77 96
4. Assertio Therapeutics (XS, US)   Pharmaceuticals
4. Assertio Therapeutics (XS, US)   Pharmaceuticals 48 92 79 92
5. Sagent (XS, US)   Pharmaceuticals
5. Sagent (XS, US)   Pharmaceuticals 59 85 72 90
6. Nektar (S, US)   Pharmaceuticals
6. Nektar (S, US)   Pharmaceuticals 18 92 100 90
7. Pfizer (XL, US)   Pharmaceuticals
7. Pfizer (XL, US)   Pharmaceuticals 68 48 87 69
8. Vivus (XS, US)   Pharmaceuticals
8. Vivus (XS, US)   Pharmaceuticals 2 67 78 67
9. Pernix Therapeutics (XS, US)   Pharmaceuticals
9. Pernix Therapeutics (XS, US)   Pharmaceuticals 71 14 13 60
10. Lannett (S, US)   Pharmaceuticals
10. Lannett (S, US)   Pharmaceuticals 41 96 75 50

January 1, 2014. Top 10s are published weekly by . ()

This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from January 1, 2014.

Top 10 Stock History D.J. US Pharmaceutical